Mission Therapeutics is a drug discovery and development company recognized as a global leader in targeting deubiquitylating enzymes. Founded in 2011, the firm is based at the Babraham Research Campus in Cambridge, United Kingdom.
Subscribe to see Mission Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mission Therapeutics is a biotechnology company headquartered in United Kingdom, founded in 2011. It has raised at least $60.1M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $13.3M in October 2025. Xcout tracks 12 named people at Mission Therapeutics, including Dr Anker Lundemose (Chief Executive Officer).
6 more named people on record for Mission Therapeutics, with roles, board committees and tenure — see the full roster →
At least $60.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $13.3M | — | |
| — | $31.8M | 1 named | |
| — | $15M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.